Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 51655-311

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 51655-311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (3a53f18e Af9b 4932 8300 B3521e87528d 01)

Chemical structure diagram of lisinopril dihydrate, part of the combination drug Lisinopril and Hydrochlorothiazide. The structure shows molecular bonds and groups including carboxyl and amine functionalities with two water molecules indicated.*

FDA Label Image

Figure 2 (3a53f18e Af9b 4932 8300 B3521e87528d 02)

Chemical structure diagram showing a molecular structure with sulfur, oxygen, chlorine, nitrogen, and other atoms, representing a chemical compound relevant to the product Lisinopril and Hydrochlorothiazide.*

FDA Label Image

Label (51655 311 26)

Label from a bottle of Lisinopril and Hydrochlorothiazide tablets USP, 20 mg/12.5 mg strength, containing 90 tablets. The label states RX only and includes storage instructions to keep at 20-25°C, protect from light and humidity, and keep out of reach of children. It also notes the product is repackaged by Northwind Pharmaceuticals.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.